Inventor profile of:

Raju Mohan

City:

Encinitas, California

Country:

United States

Published Applications:

93

Last publication date:

2025-06-26

Top Assignees for applications by Raju Mohan

The entities that hold a legal rights for patent applications filed by inventor Mohan Raju:

Recent patent applications by Mohan Raju

Raju Mohan from Encinitas, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-26
US20250206753A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#2 | 2025-05-29
US20250171446A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#3 | 2024-07-04
US20240216361A1
Human necessities

ROR-GAMMA MODULATORS

#4 | 2024-01-25
US20240025914A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#5 | 2023-11-02
US20230348478A1
Chemistry; metallurgy

TYK2 PSEUDOKINASE LIGANDS

#6 | 2023-10-26
US20230339944A1
Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#7 | 2023-10-05
US20230312589A1
Chemistry; metallurgy

JAK INHIBITORS

#8 | 2023-09-07
US20230277527A1
Human necessities

ROR-GAMMA MODULATORS

#9 | 2023-07-06
US20230212127A1
Chemistry; metallurgy

LIVER X RECEPTOR (LXR) MODULATORS

#10 | 2023-06-15
US20230183258A1
Chemistry; metallurgy

NLRP3 MODULATORS

#11 | 2023-06-15
US20230183247A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#12 | 2023-01-26
US20230024521A1
Chemistry; metallurgy

JAK INHIBITORS

#13 | 2023-01-05
US20230002394A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#14 | 2022-12-15
US20220396559A1
Chemistry; metallurgy

N-((1,2,3.5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-4, 5, 6, 7-TETRAHYDROBENZOFURAN -2-SULFONAMIDE DERIVATIVES AND RELATED COMPOUNDS AS NLPR3 MODULATORS FOR THE TREATMENT OF MULTIPLE SCLEROSIS (MS)

#15 | 2022-12-08
US20220388963A1
Chemistry; metallurgy

LIVER X RECEPTOR (LXR) MODULATORS

#16 | 2022-08-18
US20220259170A1
Chemistry; metallurgy

NLRP3 MODULATORS

#17 | 2022-07-21
US20220227767A1
Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#18 | 2022-06-09
US20220175765A1
Human necessities

ROR-GAMMA MODULATORS

#19 | 2022-06-02
US20220169651A1
Chemistry; metallurgy

TYK2 pseudokinase ligands

#20 | 2022-05-05
US20220135567A1
Chemistry; metallurgy

TYK2 PSEUDOKINASE LIGANDS

#21 | 2022-04-07
US20220106329A1
Chemistry; metallurgy

BICYCLIC ROR-GAMMA MODULATORS

#22 | 2022-04-07
US20220106323A1
Chemistry; metallurgy

SPIROCYCLIC ROR-GAMMA MODULATORS

#23 | 2022-04-07
US20220106274A1
Chemistry; metallurgy

LIVER X RECEPTOR (LXR) MODULATORS

#24 | 2021-09-23
US20210292336A1
Chemistry; metallurgy

NLRP3 modulators

#25 | 2021-09-02
US20210269406A1
Chemistry; metallurgy

LIVER X RECEPTOR (LXR) MODULATORS

#26 | 2021-07-15
US20210214362A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#27 | 2021-06-03
US20210163485A1
Chemistry; metallurgy

Heterocyclic Compounds for the Treatment of Disease

#28 | 2021-05-20
US20210147426A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#29 | 2021-05-13
US20210139490A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#30 | 2021-05-13
US20210139486A1
Chemistry; metallurgy

Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligands

#31 | 2021-04-08
US20210101895A1
Chemistry; metallurgy

LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS

#32 | 2021-03-11
US20210069182A1
Human necessities

ROR-GAMMA MODULATORS

#33 | 2021-02-25
US20210053987A1
Chemistry; metallurgy

Bicyclic RORΞ³ modulators

#34 | 2021-02-25
US20210053976A1
Chemistry; metallurgy

Spirocyclic ROR-gamma modulators

#35 | 2021-02-11
US20210040100A1
Chemistry; metallurgy

Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitors

#36 | 2020-12-31
US20200407364A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS

#37 | 2020-12-24
US20200397798A1
Human necessities

COMBINATION THERAPIES WITH FARNESOID X RECEPTOR (FXR) MODULATORS

#38 | 2020-11-26
US20200369669A1
Chemistry; metallurgy

JAK inhibitors

#39 | 2020-10-15
US20200325140A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#40 | 2020-10-15
US20200325135A1
Chemistry; metallurgy

HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#41 | 2020-03-12
US20200079782A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#42 | 2020-03-05
US20200071327A1
Chemistry; metallurgy

Prodrugs for the Treatment of Disease

#43 | 2019-10-10
US20190308977A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

#44 | 2019-09-05
US20190269674A1
Human necessities

Substituted piperazines as ROR-gamma modulators

#45 | 2019-08-08
US20190241556A1
Chemistry; metallurgy

Heterocyclic compounds for the treatment of disease

#46 | 2019-07-11
US20190211026A1
Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#47 | 2019-06-06
US20190169131A1
Chemistry; metallurgy

Liver X receptor (LXR) modulators

#48 | 2018-12-06
US20180346473A1
Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS

#49 | 2018-05-03
US20180118752A1
Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#50 | 2017-12-14
US20170355704A1
Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#51 | 2017-12-14
US20170355699A1
Chemistry; metallurgy

Fused bicyclic compounds for the treatment of disease

#52 | 2016-10-20
US20160304499A1
Chemistry; metallurgy

LXR modulators

#53 | 2016-10-06
US20160289222A1
Chemistry; metallurgy

LXR modulators

#54 | 2015-10-22
US20150299136A1
Chemistry; metallurgy

LXR MODULATORS

#55 | 2015-02-12
US20150045399A1
Chemistry; metallurgy

Liver X receptor (LXR) modulators for the treatment of dermal diseases, disorders and conditions

#56 | 2014-06-12
US20140163081A1
Chemistry; metallurgy

LXR MODULATORS

#57 | 2014-02-06
US20140038964A1
Chemistry; metallurgy

Imidazole based LXR modulators

#58 | 2013-11-14
US20130303505A1
Chemistry; metallurgy

TGR5 agonists

#59 | 2012-03-22
US20120071534A1
Chemistry; metallurgy

LXR modulators

#60 | 2012-02-16
US20120040985A1
Chemistry; metallurgy

Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity

#61 | 2011-12-08
US20110301128A1
Chemistry; metallurgy

Pyrrole derivatives as pharmaceutical agents

#62 | 2011-10-27
US20110263673A1
Chemistry; metallurgy

Atropisomers of (hydroxyalkyl) pyrrole derivatives

#63 | 2011-10-27
US20110263544A1
Chemistry; metallurgy

1-phenylpyrrole derivatives

#64 | 2011-08-16
US10327813
-

Modulators of LXR

#65 | 2011-06-16
US20110144128A1
Chemistry; metallurgy

Heterocyclic Carboxamide Compounds as Steroid Nuclear Receptors Ligands

#66 | 2010-12-30
US20100331295A1
Chemistry; metallurgy

Modulators of LXR

#67 | 2010-07-08
US20100173824A1
Chemistry; metallurgy

Azepinoindole derivatives as pharmaceutical agents

#68 | 2010-04-29
US20100105675A2
Chemistry; metallurgy

11 Ξ²-HSD1 modulators

#69 | 2010-03-25
US20100075964A1
Chemistry; metallurgy

Imidazole based LXR modulators

#70 | 2010-03-18
US20100069367A1
Chemistry; metallurgy

LXR and FXR modulators

#71 | 2010-03-04
US20100056582A1
Chemistry; metallurgy

Modulators of LXR

#72 | 2009-10-01
US20090247515A1
Chemistry; metallurgy

11 Beta-HSD1 Modulators

#73 | 2009-08-13
US20090203577A1
Chemistry; metallurgy

Azepinoindole Derivatives As Pharmaceutical Agents

#74 | 2009-08-06
US20090197870A1
Chemistry; metallurgy

Benzylthiazolone inhibitors of estrogen-related receptors (ERR)

#75 | 2009-04-09
US20090093520A1
Chemistry; metallurgy

Plasma carboxypeptidase B inhibitors

#76 | 2008-09-25
US20080234270A1
Chemistry; metallurgy

Pyrrole derivatives as pharmaceutical agents

#77 | 2008-06-05
US20080132521A1
Chemistry; metallurgy

Isoquinolinone Derivatives and Their Use As Therapeutic Agents

#78 | 2008-05-22
US20080119488A1
Chemistry; metallurgy

Modulators Of Nuclear Receptors

#79 | 2007-12-20
US20070293464A1
Human necessities

Substituted pyrimidine compositions and methods of use

#80 | 2007-09-27
US20070225377A1
Chemistry; metallurgy

Bridged ring structures as pharmaceutical agents

#81 | 2007-09-04
US10738964
-

Isoquinolinone derivatives and their use as therapeutic agents

#82 | 2006-11-02
US20060247213A1
Chemistry; metallurgy

Plasma carboxypeptidase B inhibitors

#83 | 2006-06-29
US20060142363A1
Chemistry; metallurgy

Imidazolidinedione analogs useful as anticoagulants and antithrombotics

#84 | 2006-06-22
US20060135532A1
Chemistry; metallurgy

Platelet adenosine diphosphate receptor antagonists

#85 | 2006-06-08
US20060122188A1
Chemistry; metallurgy

Platelet adenosine diphosphate receptor antagonists

#86 | 2006-06-06
US10731815
-

Platelet adenosine diphosphate receptor antagonists

#87 | 2006-05-30
US10668920
-

Imidazolidinedione analogs useful as anticoagulants and antithrombotics

#88 | 2006-05-04
US20060094725A1
Chemistry; metallurgy

N-heterocyclic derivatives as NOS inhibitors

#89 | 2005-04-14
US20050080111A1
Chemistry; metallurgy

Modulators of LXR

#90 | 2005-03-24
US20050065163A1
Chemistry; metallurgy

Platelet adenosine diphosphate receptor antagonists

#91 | 2005-03-10
US20050054634A1
Chemistry; metallurgy

Azepinoindole derivatives as pharmaceutical agents

#92 | 2005-03-01
US10163742
-

Platelet adenosine diphosphate receptor antagonists

#93 | 2005-02-17
US20050038037A1
Chemistry; metallurgy

Platelet adenosine diphosphate receptor antagonists

InventorID:

530056 ⎘